CLINICAL_TRIALS
trial_result
· 2021-04-12
Clinical Trial Update: Phase 2b Study in NASH to Assess IVA337 [Phase 2]
Summary
Phase 2b study in NASH (IVA337) has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Inventiva Pharma | Conditions: Non-Alcoholic Steatohepatitis (NASH) | Phase 2 | Status: COMPLETED | Results posted: 2021-04-12